Neoadjuvant treatment for borderline resectable pancreatic adenocarcinoma is associated with higher R0 rate compared to upfront surgery.

Autor: Terlizzi, Mario1, Buscail, Etienne2, Boussari, Olayidé3, Adgié, Sarah1, Leduc, Nicolas1, Terrebonne, Eric4, Smith, Denis4, Blanc, Jean-Frédéric4, Lapuyade, Bruno5, Laurent, Christophe2, Chiche, Laurence2, Belleannée, Geneviève6, Le Malicot, Karine3, Trouette, Renaud1, Pouypoudat, Claudia1, Vendrely, Véronique1,2,3,4,5,6,7
Zdroj: Acta Oncologica. Sep2021, Vol. 60 Issue 9, p1114-1121. 8p. 1 Diagram, 3 Charts, 1 Graph.
Databáze: Academic Search Ultimate